有轻中度基线残疾的老年脑卒中患者的机械取栓。

Q1 Medicine Interventional Neurology Pub Date : 2018-04-01 Epub Date: 2018-03-20 DOI:10.1159/000487333
Diana E Slawski, Hisham Salahuddin, Julie Shawver, Cynthia L Kenmuir, Gretchen E Tietjen, Andrea Korsnack, Syed F Zaidi, Mouhammad A Jumaa
{"title":"有轻中度基线残疾的老年脑卒中患者的机械取栓。","authors":"Diana E Slawski,&nbsp;Hisham Salahuddin,&nbsp;Julie Shawver,&nbsp;Cynthia L Kenmuir,&nbsp;Gretchen E Tietjen,&nbsp;Andrea Korsnack,&nbsp;Syed F Zaidi,&nbsp;Mouhammad A Jumaa","doi":"10.1159/000487333","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The number of elderly patients suffering from ischemic stroke is rising. Randomized trials of mechanical thrombectomy (MT) generally exclude patients over the age of 80 years with baseline disability. The aim of this study was to understand the efficacy and safety of MT in elderly patients, many of whom may have baseline impairment.</p><p><strong>Methods: </strong>Between January 2015 and April 2017, 96 patients ≥80 years old who underwent MT for stroke were selected for a chart review. The data included baseline characteristics, time to treatment, the rate of revascularization, procedural complications, mortality, and 90-day good outcome defined as a modified Rankin Scale (mRS) score of 0-2 or return to baseline.</p><p><strong>Results: </strong>Of the 96 patients, 50 had mild baseline disability (mRS score 0-1) and 46 had moderate disability (mRS score 2-4). Recanalization was achieved in 84% of the patients, and the rate of symptomatic hemorrhage was 6%. At 90 days, 34% of the patients had a good outcome. There were no significant differences in good outcome between those with mild and those with moderate baseline disability (43 vs. 24%, <i>p</i> = 0.08), between those aged ≤85 and those aged > 85 years (40.8 vs. 26.1%, <i>p</i> = 0.19), and between those treated within and those treated beyond 8 h (39 vs. 20%, <i>p</i> = 0.1). The mortality rate was 38.5% at 90 days. The Alberta Stroke Program Early CT Score (ASPECTS) and the National Institutes of Health Stroke Scale (NIHSS) predicted good outcome regardless of baseline disability (<i>p</i> < 0.001 and <i>p</i> = 0.009, respectively).</p><p><strong>Conclusion: </strong>Advanced age, baseline disability, and delayed treatment are associated with sub-optimal outcomes after MT. However, redefining good outcome to include return to baseline functioning demonstrates that one-third of this patient population benefits from MT, suggesting the real-life utility of this treatment.</p>","PeriodicalId":46280,"journal":{"name":"Interventional Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000487333","citationCount":"31","resultStr":"{\"title\":\"Mechanical Thrombectomy in Elderly Stroke Patients with Mild-to-Moderate Baseline Disability.\",\"authors\":\"Diana E Slawski,&nbsp;Hisham Salahuddin,&nbsp;Julie Shawver,&nbsp;Cynthia L Kenmuir,&nbsp;Gretchen E Tietjen,&nbsp;Andrea Korsnack,&nbsp;Syed F Zaidi,&nbsp;Mouhammad A Jumaa\",\"doi\":\"10.1159/000487333\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The number of elderly patients suffering from ischemic stroke is rising. Randomized trials of mechanical thrombectomy (MT) generally exclude patients over the age of 80 years with baseline disability. The aim of this study was to understand the efficacy and safety of MT in elderly patients, many of whom may have baseline impairment.</p><p><strong>Methods: </strong>Between January 2015 and April 2017, 96 patients ≥80 years old who underwent MT for stroke were selected for a chart review. The data included baseline characteristics, time to treatment, the rate of revascularization, procedural complications, mortality, and 90-day good outcome defined as a modified Rankin Scale (mRS) score of 0-2 or return to baseline.</p><p><strong>Results: </strong>Of the 96 patients, 50 had mild baseline disability (mRS score 0-1) and 46 had moderate disability (mRS score 2-4). Recanalization was achieved in 84% of the patients, and the rate of symptomatic hemorrhage was 6%. At 90 days, 34% of the patients had a good outcome. There were no significant differences in good outcome between those with mild and those with moderate baseline disability (43 vs. 24%, <i>p</i> = 0.08), between those aged ≤85 and those aged > 85 years (40.8 vs. 26.1%, <i>p</i> = 0.19), and between those treated within and those treated beyond 8 h (39 vs. 20%, <i>p</i> = 0.1). The mortality rate was 38.5% at 90 days. The Alberta Stroke Program Early CT Score (ASPECTS) and the National Institutes of Health Stroke Scale (NIHSS) predicted good outcome regardless of baseline disability (<i>p</i> < 0.001 and <i>p</i> = 0.009, respectively).</p><p><strong>Conclusion: </strong>Advanced age, baseline disability, and delayed treatment are associated with sub-optimal outcomes after MT. However, redefining good outcome to include return to baseline functioning demonstrates that one-third of this patient population benefits from MT, suggesting the real-life utility of this treatment.</p>\",\"PeriodicalId\":46280,\"journal\":{\"name\":\"Interventional Neurology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000487333\",\"citationCount\":\"31\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventional Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000487333\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/3/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000487333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/3/20 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 31

摘要

背景:老年缺血性脑卒中患者数量呈上升趋势。机械取栓(MT)的随机试验通常排除80岁以上基线残疾的患者。本研究的目的是了解MT在老年患者中的有效性和安全性,其中许多患者可能有基线损害。方法:选取2015年1月至2017年4月期间96例≥80岁接受脑卒中MT治疗的患者进行图表回顾。数据包括基线特征、治疗时间、血运重建率、手术并发症、死亡率和90天的良好结果,定义为修改的Rankin量表(mRS)评分0-2或恢复到基线。结果:96例患者中,50例为轻度基线残疾(mRS评分0-1),46例为中度残疾(mRS评分2-4)。84%的患者实现了再通,症状性出血率为6%。90天时,34%的患者预后良好。轻度和中度基线残疾患者的良好结局无显著差异(43比24%,p = 0.08),年龄≤85岁和> 85岁患者的良好结局无显著差异(40.8比26.1%,p = 0.19), 8小时内和8小时以上患者的良好结局无显著差异(39比20%,p = 0.1)。90天死亡率为38.5%。阿尔伯塔卒中项目早期CT评分(ASPECTS)和美国国立卫生研究院卒中量表(NIHSS)预测,无论基线残疾如何,预后良好(p < 0.001和p = 0.009)。结论:高龄、基线残疾和延迟治疗与MT后的次优结果相关。然而,重新定义良好结果以包括恢复基线功能表明三分之一的患者群体受益于MT,表明这种治疗的现实效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Mechanical Thrombectomy in Elderly Stroke Patients with Mild-to-Moderate Baseline Disability.

Background: The number of elderly patients suffering from ischemic stroke is rising. Randomized trials of mechanical thrombectomy (MT) generally exclude patients over the age of 80 years with baseline disability. The aim of this study was to understand the efficacy and safety of MT in elderly patients, many of whom may have baseline impairment.

Methods: Between January 2015 and April 2017, 96 patients ≥80 years old who underwent MT for stroke were selected for a chart review. The data included baseline characteristics, time to treatment, the rate of revascularization, procedural complications, mortality, and 90-day good outcome defined as a modified Rankin Scale (mRS) score of 0-2 or return to baseline.

Results: Of the 96 patients, 50 had mild baseline disability (mRS score 0-1) and 46 had moderate disability (mRS score 2-4). Recanalization was achieved in 84% of the patients, and the rate of symptomatic hemorrhage was 6%. At 90 days, 34% of the patients had a good outcome. There were no significant differences in good outcome between those with mild and those with moderate baseline disability (43 vs. 24%, p = 0.08), between those aged ≤85 and those aged > 85 years (40.8 vs. 26.1%, p = 0.19), and between those treated within and those treated beyond 8 h (39 vs. 20%, p = 0.1). The mortality rate was 38.5% at 90 days. The Alberta Stroke Program Early CT Score (ASPECTS) and the National Institutes of Health Stroke Scale (NIHSS) predicted good outcome regardless of baseline disability (p < 0.001 and p = 0.009, respectively).

Conclusion: Advanced age, baseline disability, and delayed treatment are associated with sub-optimal outcomes after MT. However, redefining good outcome to include return to baseline functioning demonstrates that one-third of this patient population benefits from MT, suggesting the real-life utility of this treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Interventional Neurology
Interventional Neurology CLINICAL NEUROLOGY-
自引率
0.00%
发文量
0
期刊最新文献
Recanalization of Tandem Vertebrobasilar Occlusions with Contralateral Vertebral Occlusion or Hypoplasia via either Direct Passage or the SHERPA Technique. Does the Addition of Non-Approved Inclusion and Exclusion Criteria for rtPA Impact Treatment Rates? Findings in Australia, the UK, and the USA. In vitro Remote Aspiration Embolectomy for the Treatment of Acute Ischemic Stroke. Endovascular Reperfusion for Acute Isolated Cervical Carotid Occlusions: The Concept of "Hemodynamic Thrombectomy". An Appraisal of the 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1